Home » Topics » Regulatory

Regulatory
RSS

FDA grants approval for Debiopharm's Trelstar LA for use in advanced prostate cancer

July 6, 2001

Old drug for diabetic neuropathy may be useful in migraine prophylaxis

July 4, 2001

Schering-Plough seeks FDA approval for new formulation of PEG-Intron

July 4, 2001

CollaGenex launches tablet formulation of Periostat

July 3, 2001

Further study of zonisamide for migraine/headache prophylaxis appears appropriate

July 3, 2001

Adjunctive therapy with tizanidine for migraine prophylaxis

July 2, 2001

Potential of topiramate for diabetes explored using animal models

July 2, 2001

Prophylaxis of refractory migraine with levetiracetam discussed at IHC 2001

July 2, 2001

FDA approves new formulation of Reminyl

June 29, 2001

Fujisawa's Protopic approved in Canada

June 28, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...